Piracetam--a drug for decreasing potency?
Hofmann, N.
Die Medizinische Welt 29(26): 1096-1099
1978
ISSN/ISBN: 0025-8512 PMID: 672574 Document Number: 133759
Document emailed within 1 workday
Related Documents
Jackson, J.E.; Tally, J.D.; Ellis, W.Y.; Mebrahtu, Y.B.; Lawyer, P.G.; Were, J.B.; Reed, S.G.; Panisko, D.M.; Limmer, B.L. 1990: Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy American Journal of Tropical Medicine and Hygiene 43(5): 464-480Korányi, L.; Endröczi, E. 1983: Piracetam modifies morphine and related drug-induced elevation of serum corticosterone concentration in rats Acta Physiologica Hungarica 62(1): 75-83
Korja, M.; Lehto, H.; Juvela, S.; Kaprio, J. 2016: Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates Duodecim; Laaketieteellinen Aikakauskirja 132(18): 1668
Nosov, N.N.; Tarasov, V.K. 1999: The acceptance of a strategy for decreasing the risk of contracting an HIV infection among drug abusers Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 96-97
Mendelsohn, L.G.; Johnson, B.G.; Scott, W.L.; Frederickson, R.C. 1985: Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo Journal of Pharmacology and Experimental Therapeutics 234(2): 386-390
Kilkenny, A.E.; Morgan, D.; Spangler, E.F.; Yuspa, S.H. 1985: Correlation of initiating potency of skin carcinogens with potency to induce resistance to terminal differentiation in cultured mouse keratinocytes Cancer Research 45(5): 2219-2225
Mosoko, J.J.; Akam, W.; Weidle, P.J.; Brooks, J.T.; Aweh, A.J.; Kinge, T.N.; Pals, S.; Raghunathan, P.L. 2011: Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon Journal of the International Aids Society 14: 32
Railan, D.; Wilson, J.K.; Feldman, S.R.; Fleischer, A.B. 2002: Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency Dermatology Online Journal 8(2): 3
Endo, Y.; Tsuriya, S.; Fujihira, E. 1981: Hepatic drug-metabolizing enzyme activities and anti-inflammatory potency of hydrocortisone in rats with granulomatous inflammation Research Communications in Chemical Pathology and Pharmacology 33(2): 195-206
Badyra, B.; Lisowski, B.; Polak, S.; Kudolo, J.; Wiśniowska, B. 2015: How in vitro influences in silico utilized for the prediction of in vivo - pilot study of the drug-induced pro-arrhythmic potency prediction Folia Medica Cracoviensia 55(4): 5-19
Damasceno, A.; Caupers, P.; Rafik, A.; Santos, A.; Polónia, J. 1999: The additional efficacy of the nifedipine-diuretic combination depends on the potency of the drug administered first and not the sequence of administration. a double blind study in salt-sensitive black hypertensives Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18(1): 9-19
Picciòla, G. 1979: Glutamminic derivatives of piracetam Bollettino Chimico Farmaceutico 118(5): 282-285
Klink, F.; Grosspietzsch, R.; von Klitzing, L.; Oberheuser, F. 1979: The protective effect of piracetam during delivery Fortschritte der Medizin 97(46): 2163-2165
Ostrovskaia, R.U.; Molodavkin, G.M.; Trofimov, S.S.; Popova, R.I.; Gudasheva, T.A. 1982: Neuropharmacological properties of piracetam derivatives Biulleten' Eksperimental'noi Biologii i Meditsiny 94(12): 62-65
Platt, D.; Mühlberg, W.; Rieck, W. 1985: The effect of age on clinical pharmacokinetics of piracetam Arzneimittel-Forschung 35(2): 533-535
Wilsher, C.R.; Bennett, D.; Chase, C.H.; Conners, C.K.; DiIanni, M.; Feagans, L.; Hanvik, L.J.; Helfgott, E.; Koplewicz, H.; Overby, P. 1987: Piracetam and dyslexia: effects on reading tests Journal of Clinical Psychopharmacology 7(4): 230-237
Strnad, P.; Bystrický, Z. 1985: Severe intracranial injuries and their treatment using piracetam Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 64(8-9): 612-619
Nikolova, M. 1981: Experimental electroencephalographic study of piracetam in cats Methods and Findings in Experimental and Clinical Pharmacology 3(6): 367-375
Sikora, J.; Kabes, J.; Pisvejc, J. 1981: Management of neuroleptic side-effects with piracetam Ceskoslovenska Psychiatrie 77(2): 137-142
Allikmets, L.H.; Rägo, L.K.; Otter, M.J. 1983: Effect of piracetam on central serotoninergic processes Activitas Nervosa Superior 25(1): 61-63